FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Commun Biol / Bile acids segregate metabolic syndrome in a cohort of 100 d...
Communications biology2025; 8(1); 1711; doi: 10.1038/s42003-025-09111-7

Bile acids segregate metabolic syndrome in a cohort of 100 deeply phenotyped horses.

Abstract: Metabolic syndrome (MetS)-encompassing obesity, insulin resistance, dyslipidemia, and hypertension-is prevalent in both humans and horses, offering a unique opportunity to explore shared pathophysiological mechanisms across species in a controlled model organism. In this first report from the Pioneer 100 Horse Health Project (P100HHP), we conducted a longitudinal, multi-omic analysis of 108 deeply phenotyped horses to interrogate individual health trajectories for precision insights into MetS. We identified two primary metabotypes: one characterized by elevated unsaturated triglycerides (TGs) and the other by increased levels of primary bile acids (BAs), notably taurocholic acid and taurochenodeoxycholic acid. Horses with higher circulating levels of taurocholic acid had significantly higher plasma insulin concentrations, especially after an oral sugar challenge (P = 0.01), indicating that specific BAs are associated with hyperinsulinemia-a key phenotype of MetS. Metabolomic signatures predicted body condition score (relative adiposity) with high performance, underscoring their potential for precision diagnostics. Seasonal variations influenced BA levels and were associated with shifts in the fecal microbiota, particularly in Clostridium and Proteobacteria populations. Additionally, we observed an inverse relationship between genetic diversity-measured by runs of homozygosity-and insulin levels, suggesting a genetic component to MetS susceptibility. Our findings demonstrate the power of deep phenotyping and multi-omic approaches to effectively delineate MetS subtypes in horses, highlighting the pivotal roles of bile acids and the microbiome in MetS pathogenesis. These insights not only advance the understanding of equine MetS but also establish the horse as a valuable translational model for human MetS, with potential implications for targeted diagnostics and therapeutics in both veterinary and human medicine.
© 2025. The Author(s).
Get Full Text
Publication Date: 2025-11-27 PubMed ID: 41310118PubMed Central: PMC12660777DOI: 10.1038/s42003-025-09111-7Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study analyzed metabolic syndrome (MetS) in a well-characterized population of 108 horses to identify different metabolic profiles and their relation to disease features such as insulin resistance and obesity.
  • It highlighted the role of bile acids and gut microbiota in MetS and proposed horses as a useful model for understanding and diagnosing MetS in both animals and humans.

Study Context and Objectives

  • Metabolic syndrome (MetS) includes a cluster of conditions: obesity, insulin resistance, dyslipidemia, and hypertension.
  • MetS is common in both humans and horses, making horses a valuable controlled model to explore shared biological mechanisms across species.
  • The Pioneer 100 Horse Health Project (P100HHP) aimed to deeply phenotype 108 horses longitudinally, collecting multi-omic data to understand individual variations in health and MetS progression.

Key Findings and Metabotypes Identified

  • Two primary metabolic profiles (metabotypes) were discovered among the horses:
    • One group showed elevated levels of unsaturated triglycerides (TGs).
    • The other group exhibited increased levels of primary bile acids (BAs), specifically taurocholic acid and taurochenodeoxycholic acid.
  • Horses with higher circulating taurocholic acid levels exhibited significantly higher plasma insulin concentrations, particularly after an oral sugar challenge, linking these bile acids to hyperinsulinemia, a hallmark of MetS.

Diagnostic and Predictive Potential

  • Metabolomic signatures correlated strongly with body condition score (a measure of relative adiposity), suggesting metabolites could serve as precise diagnostic tools for MetS.

Influence of Season and Microbiome

  • Seasonal changes affected bile acid levels in the horses.
  • These variations were associated with shifts in gut microbial populations, especially bacteria from the Clostridium and Proteobacteria groups.
  • The findings emphasize the interaction between bile acids and the gut microbiome as an important factor in MetS development.

Genetics and MetS Susceptibility

  • An inverse relationship was found between genetic diversity (measured by runs of homozygosity) and insulin levels.
  • This suggests a genetic predisposition to MetS, where lower genetic diversity may increase susceptibility to insulin dysregulation.

Implications and Significance

  • The study demonstrates that deep phenotyping combined with multi-omic analyses can effectively stratify MetS subtypes in horses, enabling precision insights.
  • It identifies bile acids and the microbiome as key players in MetS pathogenesis.
  • By establishing horses as a translational model, the research opens opportunities for developing targeted diagnostics and treatments applicable to veterinary and human metabolic disorders.

Cite This Article

APA
Donnelly CG, Peng S, Pflieger L, Manfredi J, Coleman M, Rappaport N, Price ND, Finno CJ. (2025). Bile acids segregate metabolic syndrome in a cohort of 100 deeply phenotyped horses. Commun Biol, 8(1), 1711. https://doi.org/10.1038/s42003-025-09111-7

Publication

Communications biology
ISSN: 2399-3642
NlmUniqueID: 101719179
Country: England
Language: English
Volume: 8
Issue: 1
Pages: 1711
PII: 1711

Researcher Affiliations

Donnelly, Callum G
  • College of Veterinary Medicine, Cornell University, Ithaca, NY, USA. cgd43@cornell.edu.
Peng, Sichong
  • EclipseBio, San Diego, CA, USA.
Pflieger, Lance
  • Phenome Health, Seattle, WA, USA.
Manfredi, Jane
  • College of Veterinary Medicine, Michigan State University, East Lansing, MI, USA.
Coleman, Michele
  • College of Veterinary Medicine, Georgia State University, Athens, GA, USA.
Rappaport, Noa
  • Phenome Health, Seattle, WA, USA.
  • Institue of Systems Biology, Seattle, WA, USA.
Price, Nathan D
  • Buck Institute for Research on Aging, Novato, CA, USA.
  • Thorne, New York, NY, USA.
Finno, Carrie J
  • School of Veterinary Medicine, University of California, Davis, CA, USA.

MeSH Terms

  • Animals
  • Metabolic Syndrome / veterinary
  • Metabolic Syndrome / blood
  • Metabolic Syndrome / metabolism
  • Horses
  • Bile Acids and Salts / metabolism
  • Bile Acids and Salts / blood
  • Horse Diseases / blood
  • Horse Diseases / metabolism
  • Phenotype
  • Male
  • Female

Grant Funding

  • D21EQ-050 / Morris Animal Foundation (MAF)

Conflict of Interest Statement

Competing interests: The authors declare no competing interests.

References

This article includes 57 references
  1. Durham AE. ECEIM consensus statement on equine metabolic syndrome.. 335–349 (2019).
    doi: 10.1111/jvim.15423pmc: PMC6430910pubmed: 30724412google scholar: lookup
  2. Ahmed M. Metabolic syndrome; definition, pathogenesis, elements, and the effects of medicinal plants on it’s elements.. 1011–1022 (2022).
    doi: 10.1007/s40200-021-00965-2pmc: PMC9167315pubmed: 35673459google scholar: lookup
  3. Thatcher CD, Pleasant RS, Geor RJ, Elvinger F. Prevalence of overconditioning in mature horses in southwest Virginia during the summer.. 1413–1418 (2012).
    doi: 10.1111/j.1939-1676.2012.00995.xpubmed: 22946995google scholar: lookup
  4. Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014.. 2284–2291 (2016).
    doi: 10.1001/jama.2016.6458pmc: PMC11197437pubmed: 27272580google scholar: lookup
  5. Ojanen X. Towards early risk biomarkers: serum metabolic signature in childhood predicts cardio-metabolic risk in adulthood.. 103611 (2021).
    doi: 10.1016/j.ebiom.2021.103611pmc: PMC8511803pubmed: 34628356google scholar: lookup
  6. Hyötyläinen, T. in: (eds Orešič, M. & Vidal-Puig, A.) (Springer, 2014).
  7. Fromentin S. Microbiome and metabolome features of the cardiometabolic disease spectrum.. 303–314 (2022).
    doi: 10.1038/s41591-022-01688-4pmc: PMC8863577pubmed: 35177860google scholar: lookup
  8. Hu X. Alterations of gut microbiome and serum metabolome in coronary artery disease patients complicated with non-alcoholic fatty liver disease are associated with adverse cardiovascular outcomes.. 805812 (2022).
    doi: 10.3389/fcvm.2021.805812pmc: PMC8761954pubmed: 35047580google scholar: lookup
  9. Vallianou N. Understanding the role of the gut microbiome and microbial metabolites in non-alcoholic fatty liver disease: current evidence and perspectives.. 56 (2021).
    doi: 10.3390/biom12010056pmc: PMC8774162pubmed: 35053205google scholar: lookup
  10. Hild B. Neonatal exposure to a wild-derived microbiome protects mice against diet-induced obesity.. 1042–1057 (2021).
    doi: 10.1038/s42255-021-00439-ypmc: PMC9969744pubmed: 34417593google scholar: lookup
  11. Diener C. Baseline gut metagenomic functional gene signature associated with variable weight loss responses following a healthy lifestyle intervention in humans.. e0096421 (2021).
    doi: 10.1128/msystems.00964-21pmc: PMC8547453pubmed: 34519531google scholar: lookup
  12. Sonnenburg JL, Sonnenburg ED. Vulnerability of the industrialized microbiota.. eaaw9255 (2019).
    doi: 10.1126/science.aaw9255pubmed: 31649168google scholar: lookup
  13. Clemente JC. The microbiome of uncontacted Amerindians.. e1500183 (2015).
    doi: 10.1126/sciadv.1500183pmc: PMC4517851pubmed: 26229982google scholar: lookup
  14. Pasolli E. Extensive unexplored human microbiome diversity revealed by over 150,000 genomes from metagenomes spanning age, geography, and lifestyle.. 649–662.e20 (2019).
    doi: 10.1016/j.cell.2019.01.001pmc: PMC6349461pubmed: 30661755google scholar: lookup
  15. Rosshart SP. Wild mouse gut microbiota promotes host fitness and improves disease resistance.. 1015–1028.e13 (2017).
    doi: 10.1016/j.cell.2017.09.016pmc: PMC6887100pubmed: 29056339google scholar: lookup
  16. Rosshart SP. Laboratory mice born to wild mice have natural microbiota and model human immune responses. eaaw4361 (2019).
    doi: 10.1126/science.aaw4361pmc: PMC7377314pubmed: 31371577google scholar: lookup
  17. Orlando L. Ancient genomes reveal unexpected horse domestication and management dynamics. 1900164 (2020).
    doi: 10.1002/bies.201900164google scholar: lookup
  18. Kauter A. The gut microbiome of horses: current research on equine enteral microbiota and future perspectives. 14 (2019).
    doi: 10.1186/s42523-019-0013-3pmc: PMC7807895pubmed: 33499951google scholar: lookup
  19. Price ND. A wellness study of 108 individuals using personal, dense, dynamic data clouds. 747–756 (2017).
    doi: 10.1038/nbt.3870pmc: PMC5568837pubmed: 28714965google scholar: lookup
  20. Wilmanski T. Gut microbiome pattern reflects healthy ageing and predicts survival in humans. 274–286 (2021).
    doi: 10.1038/s42255-021-00348-0pmc: PMC8169080pubmed: 33619379google scholar: lookup
  21. Wilmanski T. Blood metabolome predicts gut microbiome α-diversity in humans. 1217–1228 (2019).
    doi: 10.1038/s41587-019-0233-9pubmed: 31477923google scholar: lookup
  22. Equine Endocrinology Group. https://sites.tufts.edu/equineendogroup/ (2022).
  23. Henneke DR, Potter GD, Kreider JL, Yeates BF. Relationship between condition score, physical measurements and body fat percentage in mares. 371–372 (1983).
    doi: 10.1111/j.2042-3306.1983.tb01826.xpubmed: 6641685google scholar: lookup
  24. Watanabe K. Multiomic signatures of body mass index identify heterogeneous health phenotypes and responses to a lifestyle intervention. 996–1008 (2023).
    doi: 10.1038/s41591-023-02248-0pmc: PMC10115644pubmed: 36941332google scholar: lookup
  25. Delarocque J. Metabolic changes induced by oral glucose tests in horses and their diagnostic use. 597–605 (2021).
    doi: 10.1111/jvim.15992pmc: PMC7848347pubmed: 33277752google scholar: lookup
  26. Coleman MC, Whitfield-Cargile CM, Madrigal RG, Cohen ND. Comparison of the microbiome, metabolome, and lipidome of obese and non-obese horses. e0215918 (2019).
    doi: 10.1371/journal.pone.0215918pmc: PMC6478336pubmed: 31013335google scholar: lookup
  27. Delarocque J. Metabolic profile distinguishes laminitis-susceptible and -resistant ponies before and after feeding a high sugar diet. 56 (2021).
    doi: 10.1186/s12917-021-02763-7pmc: PMC7841998pubmed: 33509165google scholar: lookup
  28. Patterson Rosa L, Mallicote MF, Long MT, Brooks SA. Metabogenomics reveals four candidate regions involved in the pathophysiology of equine metabolic syndrome. 101620 (2020).
    doi: 10.1016/j.mcp.2020.101620pmc: PMC7494547pubmed: 32659253google scholar: lookup
  29. Elzinga S, Wood P, Adams AA. Plasma lipidomic and inflammatory cytokine profiles of horses with equine metabolic syndrome. 49–55 (2016).
    doi: 10.1016/j.jevs.2016.01.013google scholar: lookup
  30. Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome.. 25F–29F (1999).
    doi: 10.1016/S0002-9149(99)00211-8pubmed: 10357572google scholar: lookup
  31. Shapiro H, Kolodziejczyk AA, Halstuch D, Elinav E. Bile acids in glucose metabolism in health and disease.. 383–396 (2018).
    doi: 10.1084/jem.20171965pmc: PMC5789421pubmed: 29339445google scholar: lookup
  32. Washizu T, Tomoda I, Kaneko JJ. Serum bile acid composition of the dog, cow, horse and human.. 81–86 (1991).
    doi: 10.1292/jvms.53.81pubmed: 1830784google scholar: lookup
  33. Wu T et al. Effects of taurocholic acid on glycemic, glucagon-like peptide-1, and insulin responses to small intestinal glucose infusion in healthy humans.. E718–E722 (2013).
    doi: 10.1210/jc.2012-3961pubmed: 23418316google scholar: lookup
  34. Ramírez-Pérez O, Cruz-Ramón V, Chinchilla-López P, Méndez-Sánchez N. The role of the gut microbiota in bile acid metabolism.. s15–s20 (2017).
    doi: 10.5604/01.3001.0010.5672pubmed: 29080339google scholar: lookup
  35. Figueiredo G, Gomes M, Covas C, Mendo S, Caetano T. The unexplored wealth of microbial secondary metabolites: the case study.. 470–481 (2022).
    doi: 10.1007/s00248-021-01762-3pubmed: 33987687google scholar: lookup
  36. Doden HL et al. Completion of the gut microbial epi-bile acid pathway.. 1–20 (2021).
  37. Stacpoole PW. The pharmacology of dichloroacetate.. 1124–1144 (1989).
    doi: 10.1016/0026-0495(89)90051-6pubmed: 2554095google scholar: lookup
  38. Shin NR, Whon TW, Bae JW. Proteobacteria: microbial signature of dysbiosis in gut microbiota.. 496–503 (2015).
    doi: 10.1016/j.tibtech.2015.06.011pubmed: 26210164google scholar: lookup
  39. Costa MC et al. Comparison of the fecal microbiota of healthy horses and horses with colitis by high throughput sequencing of the V3-V5 region of the 16S rRNA gene.. e41484 (2012).
    doi: 10.1371/journal.pone.0041484pmc: PMC3409227pubmed: 22859989google scholar: lookup
  40. Gurung M et al. Role of gut microbiota in type 2 diabetes pathophysiology.. 102590 (2020).
    doi: 10.1016/j.ebiom.2019.11.051pmc: PMC6948163pubmed: 31901868google scholar: lookup
  41. Julliand V, Grimm P. HORSE SPECIES SYMPOSIUM: the microbiome of the horse hindgut: history and current knowledge.. 2262–2274 (2016).
    doi: 10.2527/jas.2015-0198pubmed: 27285903google scholar: lookup
  42. Fareed M, Afzal M. Evidence of inbreeding depression on height, weight, and body mass index: a population-based child cohort study.. 784–795 (2014).
    doi: 10.1002/ajhb.22599pubmed: 25130378google scholar: lookup
  43. Fatma R, Chauhan W, Afzal M. Assessment of inbreeding depression on morphometric traits among North Indian population cohorts.. 14 (2024).
    doi: 10.1186/s12982-024-00132-xgoogle scholar: lookup
  44. Hodge E et al. Effect of thyrotropin-releasing hormone stimulation testing on the oral sugar test in horses when performed as a combined protocol.. 2272–2279 (2019).
    doi: 10.1111/jvim.15601pmc: PMC6766522pubmed: 31432575google scholar: lookup
  45. Beech J, McFarlane D, Lindborg S, Sojka JE, Boston RC. α-Melanocyte-stimulating hormone and adrenocorticotropin concentrations in response to thyrotropin-releasing hormone and comparison with adrenocorticotropin concentration after domperidone administration in healthy horses and horses with pituitary pars intermedia dysfunction.. 1305–1315 (2011).
    doi: 10.2460/javma.238.10.1305pubmed: 21568777google scholar: lookup
  46. Kerrigan LE, Thompson DL Jr, Chapman AM, Oberhaus EL. Effects of epinephrine, detomidine, and butorphanol on assessments of insulin sensitivity in mares.. 102842 (2020).
    doi: 10.1016/j.jevs.2019.102842pubmed: 31952633google scholar: lookup
  47. McMurdie PJ, Holmes S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data.. e61217 (2013).
    doi: 10.1371/journal.pone.0061217pmc: PMC3632530pubmed: 23630581google scholar: lookup
  48. Ritchie ME et al. limma powers differential expression analyses for RNA-sequencing and microarray studies.. e47 (2015).
    doi: 10.1093/nar/gkv007pmc: PMC4402510pubmed: 25605792google scholar: lookup
  49. Krueger F. Trim galore. A wrapper tool around Cutadapt and FastQC to consistently apply quality and adapter trimming to FastQ files (2015).. .
  50. Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads.. 10–12 (2011).
    doi: 10.14806/ej.17.1.200google scholar: lookup
  51. Kalbfleisch TS et al. Improved reference genome for the domestic horse increases assembly contiguity and composition.. 197 (2018).
    doi: 10.1038/s42003-018-0199-zpmc: PMC6240028pubmed: 30456315google scholar: lookup
  52. Li H, Durbin R. Fast and accurate short read alignment with Burrows–Wheeler transform.. 1754–1760 (2009).
    doi: 10.1093/bioinformatics/btp324pmc: PMC2705234pubmed: 19451168google scholar: lookup
  53. Li H et al. The sequence alignment/map format and SAMtools.. 2078–2079 (2009).
    doi: 10.1093/bioinformatics/btp352pmc: PMC2723002pubmed: 19505943google scholar: lookup
  54. Van der Auwera, G. A. & O’Connor, B. D. 1st edn (O’Reilly Media, 2020).
  55. Danecek P etr et al, 1000 Genomes Project Analysis Group. the variant call format and VCFtools.. 2156–2158 (2011).
    doi: 10.1093/bioinformatics/btr330google scholar: lookup
  56. Purcell S et al. PLINK: a toolset for whole-genome association and population-based linkage analysis.. 559–575 (2007).
  57. Narasimhan V et al. BCFtools/RoH: a hidden Markov model approach for detecting autozygosity from next-generation sequencing data.. 1749–1751 (2016).
    doi: 10.1093/bioinformatics/btw044pmc: PMC4892413pubmed: 26826718google scholar: lookup

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 99,005 horse owners like you who receive our email updates on horse health and nutrition.